Analysis by outcome
Analysis by both treatment arm and the primary study outcome (EmCS) also demonstrated the cost-saving associated with CTG+STan was present in both EmCS and non-EmCS cases, but with the finding more strongly represented in the mothers and babies who did not experience EmCS (Supplementary table 3).